OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating the potential of tauroursodeoxycholic acid as add-on therapy in amelioration of streptozotocin-induced diabetic kidney disease
Himanshu Sankrityayan, Vishwadeep Shelke, Ajinath Kale, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175528-175528
Closed Access | Times Cited: 9

Showing 9 citing articles:

CRISPR/Cas9 based knockout of lncRNA MALAT1 attenuates TGF-β1 induced Smad 2/3 mediated fibrosis during AKI-to-CKD transition
Bhupendra Puri, Syamantak Majumder, Anil Bhanudas Gaikwad
European Journal of Pharmaceutical Sciences (2025), pp. 107044-107044
Open Access | Times Cited: 1

Combination of α-Klotho and telmisartan attenuates diabetic kidney disease via mitigating EMT, inflammation and apoptosis
Anil Bhanudas Gaikwad, Aditya Dipakrao Hajare, Hrushikesh Kulkarni, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151711-151711
Closed Access

Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis
Shangze Guo, Yinghao Tong, Ting Li, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 919-919
Open Access | Times Cited: 3

Natural products derived from traditional Chinese medicines targeting ER stress for the treatment of kidney diseases
Mengping Wang, Zhengtao Chen, Ziru Tang, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 3

Novel dysregulated long non‐coding RNAs in the acute kidney injury‐to‐chronic kidney diseases transition unraveled by transcriptomic analysis
Bhupendra Puri, Syamantak Majumder, Anil Bhanudas Gaikwad
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3

Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: A potential therapeutic approach targeting TLR4-induced inflammation
Vishwadeep Shelke, Neha Dagar, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 332, pp. 122095-122095
Closed Access | Times Cited: 8

Acyl‐CoA Synthetase Long‐Chain Isoenzymes in Kidney Diseases: Mechanistic Insights and Therapeutic Implications
Swati Mishra, Vishwadeep Shelke, Anil Bhanudas Gaikwad
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Open Access | Times Cited: 1

Novel sodium tauroursodeoxycholate-based multifunctional liposomal delivery system for encapsulation of oleanolic acid and combination therapy of type 2 diabetes mellitus
Minghao Yuan, Yulu Wang, Yan Wan, et al.
International Journal of Pharmaceutics (2024), pp. 124803-124803
Closed Access | Times Cited: 1

Epigenetic regulation of mitochondrial‐endoplasmic reticulum dynamics in kidney diseases
Vishwadeep Shelke, Vinayak Yelgonde, Ajinath Kale, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 8, pp. 1716-1731
Closed Access | Times Cited: 3

Page 1

Scroll to top